Mylan Agila Unit In India Issues U.K. Recall For Injectable Antibiotic
This article was originally published in PharmAsia News
Another India drug-production site has become the source of a recall, this one producing batches of an injectable antibiotic for Mylan and its Agila unit of Strides Arcolab International.
You may also be interested in...
Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.
based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.
Pink Sheet reporters and editors discuss their take-aways from the recent advisory committee meeting on coronavirus vaccine development and approval, as well as the upcoming FDA hearing on Makena’s withdrawal.